AtomVie Opens $160 Million Radiopharmaceutical Manufacturing Facility in Ontario

AtomVie Global Radiopharma (AtomVie), a leading global Contract Development and Manufacturing Organization (CDMO) in the radiopharmaceutical industry, ce...

September 07, 2026 | Monday | News
IDT Expands Partnership With Ansa to Broaden Global Access to Complex DNA Synthesis

Integrated DNA Technologies (IDT), a Danaher company and a global leader in genomics, and Ansa Biotechnologies, Inc., a trusted partner for DNA synthesis...

September 03, 2026 | Thursday | News
Andelyn Biosciences to Scale Up Genprex’s AAV-Based Diabetes Gene Therapy Program

Andelyn Biosciences, a leading contract development and manufacturing organization, announced that Genprex, Inc. has selected Andelyn to support scale-up...

September 03, 2026 | Thursday | News
Telix Completes BiPASS Phase 3 Enrollment, Advances PSMA-PET Imaging for Earlier Prostate Cancer Diagnosis

Telix Pharmaceuticals Limited announced completion of patient enrollment in the Phase 3 BiPASS™ study of its commercial PSMA-PET imaging agent...

September 03, 2026 | Thursday | News
Teva and Trump Administration Commit to Lowering Costs of Select Medicines for U.S. Medicaid Patients

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced a shared commitment with the Trump Administration to lower the cost...

September 02, 2026 | Wednesday | News
Eisai and Biogen’s LEQEMBI Gains Canada Recommendation for Public Reimbursement in Early Alzheimer’s Disease

Eisai Co., Ltd. and Biogen Inc., announced that Canada’s Drug Agency (CDA-AMC) has issued a final recommendation supporting public reimbursement of...

September 02, 2026 | Wednesday | News
Evonik Invests CAD 150 Million in New GMP Lipid-Based Drug Manufacturing Facility in Vancouver

Evonik is investing in a new GMP drug product manufacturing facility for lipid-based drug delivery in Vancouver, Canada. The facility will increase Evoni...

August 31, 2026 | Monday | News
Teva Bids to Acquire BioXcel’s Novel At-Home Neuroscience Treatment for Agitation

Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. announced it has made a bid to acquire an innovative neurosc...

August 31, 2026 | Monday | News
Lexicon Earns Third $10 Million Milestone Payment From Novo Nordisk for LX9851

Lexicon Pharmaceuticals, Inc.  announced that it has earned a third $10 million milestone payment in 2026 from Novo Nordisk A/S following the achiev...

August 26, 2026 | Wednesday | News
Quotient Sciences on How AI Is Reshaping the CDMO–Sponsor Relationship

    As AI and digital technologies increasingly influence pharmaceutical development, CDMOs are taking on a broader role in helping sponsors im...

August 25, 2026 | Tuesday | Interaction
Milestone Pharmaceuticals Enrolls First Patient in Phase 3 Trial of Etripamil for AFib-RVR

Milestone® Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medi...

August 24, 2026 | Monday | News
Alvotech and Lotus Pharmaceutical Partner to Commercialize Two Biosimilar Candidates in U.S. and Asia

Alvotech , a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced a str...

August 24, 2026 | Monday | News
SK pharmteco Opens Expanded Manufacturing Facilities at Swords Campus in Ireland

SK pharmteco recently hosted a formal ribbon-cutting ceremony to mark the official opening of two major facility expansions at its manufacturing campus i...

August 20, 2026 | Thursday | News
Immunocine Cancer Center Opens Second Treatment Location in Cabo San Lucas

Responding to a growing number of patients seeking personalized cancer immunotherapy, Immunocine Cancer Center has opened a second treatment location in ...

August 20, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close